OBJECTIVE: Cardiomyopathy and other vascular complications are now recognized as significant components of HIV/AIDS pathogenesis. Although the mechanisms involved in cardiomyopathy are poorly defined, a role for direct retroviral action and/or focal infiltration of activated immune cells have been postulated. Here we investigated mechanisms in retrovirus associated cardiomyopathy using a well-defined mouse model of acquired immunodeficiency. METHODS: Mice were dosed with LPBM5 retrovirus; cardiac performance was assessed by echocardiography followed by tissue collection at 5 and 10 weeks post-infection. RESULTS: Contractile deficits were observed at 5 and 10 weeks post-retrovirus infection and preceded the development of overt immunodeficiency. Selective and widespread cardiac infiltration of CD68+ cells, but not neutrophils, mast cells, or eosinophils was also observed at both 5 and 10 weeks. LPBM5 retrovirus was readily detectable in cardiac samples by RT-PCR. Time dependent increases in cardiac protein nitration (biomarker of reactive nitrogen species) were observed and were correlated to the extent of cardiac dysfunction whereas no changes in NOSII occurred at 5 and 10 weeks. We corroborated the mouse findings using cardiac tissues and clinical findings from human HIV/AIDS autopsies. CONCLUSIONS: These studies demonstrated that cardiac myocyte protein nitration in AIDS related cardiomyopathies, rather than focal immune cell lesions characterize retrovirus associated cardiomyopathies and differentiate them from non-retroviral cardiomyopathies.
OBJECTIVE:Cardiomyopathy and other vascular complications are now recognized as significant components of HIV/AIDS pathogenesis. Although the mechanisms involved in cardiomyopathy are poorly defined, a role for direct retroviral action and/or focal infiltration of activated immune cells have been postulated. Here we investigated mechanisms in retrovirus associated cardiomyopathy using a well-defined mouse model of acquired immunodeficiency. METHODS:Mice were dosed with LPBM5 retrovirus; cardiac performance was assessed by echocardiography followed by tissue collection at 5 and 10 weeks post-infection. RESULTS:Contractile deficits were observed at 5 and 10 weeks post-retrovirus infection and preceded the development of overt immunodeficiency. Selective and widespread cardiac infiltration of CD68+ cells, but not neutrophils, mast cells, or eosinophils was also observed at both 5 and 10 weeks. LPBM5 retrovirus was readily detectable in cardiac samples by RT-PCR. Time dependent increases in cardiac protein nitration (biomarker of reactive nitrogen species) were observed and were correlated to the extent of cardiac dysfunction whereas no changes in NOSII occurred at 5 and 10 weeks. We corroborated the mouse findings using cardiac tissues and clinical findings from humanHIV/AIDS autopsies. CONCLUSIONS: These studies demonstrated that cardiac myocyte protein nitration in AIDS related cardiomyopathies, rather than focal immune cell lesions characterize retrovirus associated cardiomyopathies and differentiate them from non-retroviral cardiomyopathies.
Authors: Anne M Pruznak; Ly Hong-Brown; Rachel Lantry; Pengxiang She; Robert A Frost; Thomas C Vary; Charles H Lang Journal: Am J Physiol Endocrinol Metab Date: 2008-08-19 Impact factor: 4.310
Authors: Alysia A Chaves; Reshma S Baliga; Michael J Mihm; Brandon L Schanbacher; Anupam Basuray; Cynthia Liu; Angela C Cook; Leona W Ayers; John Anthony Bauer Journal: Am J Pathol Date: 2006-03 Impact factor: 4.307
Authors: Nico Reinsch; Philipp Kahlert; Stefan Esser; Andreas Sundermeyer; Katrin Neuhaus; Norbert Brockmeyer; Anja Potthoff; Raimund Erbel; Thomas Buck; Till Neumann Journal: Am J Cardiovasc Dis Date: 2011-07-30
Authors: Mohammed Khaleduzzaman; Joseph Francis; Meryll E Corbin; Elizabeth McIlwain; Marc Boudreaux; Min Du; Tim W Morgan; Karin E Peterson Journal: J Virol Date: 2007-09-12 Impact factor: 5.103
Authors: Qun Zhao; Xianxi Wang; Leif D Nelin; Yongxue Yao; Ranyia Matta; Mary E Manson; Reshma S Baliga; Xiaomei Meng; Charles V Smith; John A Bauer; Cheong-Hee Chang; Yusen Liu Journal: J Exp Med Date: 2005-12-27 Impact factor: 14.307